Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Giuliani

Showing results (41-50 of 117) with videos related to

Pageof 12
Sort By:
Studies in Health Technology and Informatics|June 30, 2023
Experience from the Development of HL7 FHIR IG for Gatekeeper ProjectRoberta Gazzarata, Catherine Chronaki, Alba Gallego, et al.
International Journal of Antimicrobial Agents|June 17, 2014
Photodynamic antibacterial and antibiofilm activity of RLP068/Cl against Staphylococcus aureus and Pseudomonas aeruginosa forming biofilms on prosthetic materialChristian Vassena, Simone Fenu, Francesco Giuliani, et al.
Studies in Health Technology and Informatics|October 23, 2023
Design and Adoption of a FHIR IG to Support a Telemonitoring Environment in Gatekeeper ProjectRoberta Gazzarata, Catherine Chronaki, Francesco Ricciardi, et al.
JMIR Human Factors|January 26, 2024
The Role of Coherent Robot Behavior and Embodiment in Emotion Perception and Recognition During Human-Robot Interaction: Experimental StudyLaura Fiorini, Grazia D'Onofrio, Alessandra Sorrentino, et al.
Expert Opinion on Therapeutic Targets|March 27, 2012
Current status of targeted therapies in advanced gastric cancerFerdinando De Vita, Francesco Giuliani, Nicola Silvestris, et al.
Chinese Clinical Oncology|September 11, 2024
Therapeutic inhibition of isocitrate dehydrogenase mutations in glioma and cholangiocarcinoma: new insights and promises-a narrative reviewValeria Internò, Assunta Melaccio, Pasquale Vitale, et al.
Frontiers in Public Health|April 18, 2022
Cellular and Humoral Immune Responses and Breakthrough Infections After Two Doses of BNT162b Vaccine in Healthcare Workers (HW) 180 Days After the Second Vaccine DoseAlessandra Mangia, Nicola Serra, Giovanna Cocomazzi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 9, 2011
Antiphase signalling in the neuroendocrine-immune system in healthy humansGianluigi Mazzoccoli, Lucia Anna Muscarella, Vito Michele Fazio, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2002
CAU-1, a subclass B3 metallo-beta-lactamase of low substrate affinity encoded by an ortholog present in the Caulobacter crescentus chromosomeJean-Denis Docquier, Fabrizio Pantanella, Francesco Giuliani, et al.
Geriatrics & Gerontology International|July 13, 2010
Neuroendocrine-immune interactions in healthy agingGianluigi Mazzoccoli, Michele Inglese, Angelo De Cata, et al.
Pageof 12

Showing results (41-50 of 117) with videos related to

Sort By:
Pageof 12
Studies in Health Technology and Informatics|June 30, 2023
Experience from the Development of HL7 FHIR IG for Gatekeeper ProjectRoberta Gazzarata, Catherine Chronaki, Alba Gallego, et al.
International Journal of Antimicrobial Agents|June 17, 2014
Photodynamic antibacterial and antibiofilm activity of RLP068/Cl against Staphylococcus aureus and Pseudomonas aeruginosa forming biofilms on prosthetic materialChristian Vassena, Simone Fenu, Francesco Giuliani, et al.
Studies in Health Technology and Informatics|October 23, 2023
Design and Adoption of a FHIR IG to Support a Telemonitoring Environment in Gatekeeper ProjectRoberta Gazzarata, Catherine Chronaki, Francesco Ricciardi, et al.
JMIR Human Factors|January 26, 2024
The Role of Coherent Robot Behavior and Embodiment in Emotion Perception and Recognition During Human-Robot Interaction: Experimental StudyLaura Fiorini, Grazia D'Onofrio, Alessandra Sorrentino, et al.
Expert Opinion on Therapeutic Targets|March 27, 2012
Current status of targeted therapies in advanced gastric cancerFerdinando De Vita, Francesco Giuliani, Nicola Silvestris, et al.
Chinese Clinical Oncology|September 11, 2024
Therapeutic inhibition of isocitrate dehydrogenase mutations in glioma and cholangiocarcinoma: new insights and promises-a narrative reviewValeria Internò, Assunta Melaccio, Pasquale Vitale, et al.
Frontiers in Public Health|April 18, 2022
Cellular and Humoral Immune Responses and Breakthrough Infections After Two Doses of BNT162b Vaccine in Healthcare Workers (HW) 180 Days After the Second Vaccine DoseAlessandra Mangia, Nicola Serra, Giovanna Cocomazzi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 9, 2011
Antiphase signalling in the neuroendocrine-immune system in healthy humansGianluigi Mazzoccoli, Lucia Anna Muscarella, Vito Michele Fazio, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2002
CAU-1, a subclass B3 metallo-beta-lactamase of low substrate affinity encoded by an ortholog present in the Caulobacter crescentus chromosomeJean-Denis Docquier, Fabrizio Pantanella, Francesco Giuliani, et al.
Geriatrics & Gerontology International|July 13, 2010
Neuroendocrine-immune interactions in healthy agingGianluigi Mazzoccoli, Michele Inglese, Angelo De Cata, et al.
Pageof 12